Merck's Stock Is Solid Like A Rock --- $MRK //// Let me show you how to sift through Merck’s income statement and statement of cash flows to understand their financials really well. We can run my discounted cash flow model together to see if the stock is a buy or a sell. We are also analyzing the financial ratios to see how they compare to their competitors. We will look at the debt of the company and equity. We will also calculate the WACC (weighted average cost of capital) so we can discount the future cash flows. Let's also look to see if the company is paying a dividend.
0:00 Opening
0:24 High Level Company Detail
2:30 Financial Review
10:16 Capital Structure
10:33 Valuation Results
11:34 More info
13:49 Financial Ratios
16:15 Competitor Analysis
16:49 Closing
This video is not investment advice. It is for entertainment purposes only. It is my opinion using publicly available information. Seek a duly licensed professional for investment advice.
- Merck develops and produces medicines, vaccines, biologic therapies and animal health products. In 2020, the company had 6 blockbuster drugs, each with over $1 billion in revenue: Keytruda, a humanized antibody used in cancer immunotherapy that had $14.3 billion in 2020 revenue; Januvia, an anti-diabetic medication used to treat type 2 diabetes
that had $5.3 billion; Gardasil, an HPV vaccine that had $3.9 billion; Varivax, a varicella vaccine used to protect against chickenpox that had $1.9 billion; Bridion, a neuromuscular-blocking drug that had $1.2 billion; and Pneumovax 23, a pneumococcal polysaccharide vaccine that had $1.1 billion. Other major products by the company include Isentress, an
antiretroviral medication used to treat HIV/AIDS that had $857 million Simponi (sum-pony), a human monoclonal antibody used as an immunosuppressive drug that had $838 million; RotaTeq, a rotavirus vaccine that had $797 million; and Lynparza, a medication for the maintenance treatment of advanced ovarian cancer in adults that generated $725 million
- The company is headquartered in Kenilworth, NJ and was founded in 1891
- It trades on the NYSE, Deutsche Borse, Mexican Bolsa, Euronext Paris, Xetra, Vienna, EuroTLX, Swiss, Santiago, Bulgaria, Sao Paulo, Lima, Buenos Aires & LSE
SUBSCRIBE:
Please subscribe to my channel:
[ Ссылка ]
Discord: [ Ссылка ]
MEMBERSHIP LEVELS:
If you'd like me to do a: (i) custom valuation for a stock of your choice for $9.99 per month or (iii) show your support for this channel for $0.99 per month, you can become a member by clicking on the link below:
[ Ссылка ]
MORE STOCK VIDEOS:
AbbVie: [ Ссылка ]
Amgen: [ Ссылка ]
AstraZeneca: [ Ссылка ]
Biogen: [ Ссылка ]
Bristol-Myers Squibb: [ Ссылка ]
Gilead: [ Ссылка ]
GlaxoSmithKline: [ Ссылка ]
GW Pharmaceuticals: [ Ссылка ]
Horizon Therapeutics: [ Ссылка ]
Johnson & Johnson: [ Ссылка ]
Eli Lilly: [ Ссылка ]
Merck: [ Ссылка ]
Novartis: [ Ссылка ]
Organon: [ Ссылка ]
Pfizer: [ Ссылка ]
CONTACT:
financial.business.consultant.sr@gmail.com
Discounted cash flow (DCF) is a valuation method used to estimate the value of an investment based on its future cash flows. DCF analysis attempts to figure out the value of an investment today, based on projections of how much money it will generate in the future.
This video is not investment advice. It is for entertainment purposes only. It is my opinion using publicly available information. Seek a duly licensed professional for investment advice.
Merck's Stock Is Solid Like A Rock --- $MRK
Теги
scott rubindiscounted cash flowdiscounted cash flow valuationdiscounted cash flow modeldiscounted cash flow analysisdiscounted cash flow exceldiscounted cash flow explainedmrk stockmerck stockmrk stock analysismerck stock analysismerck & co stockmerck stock 2021mrk dividendis mrk stock a good buymerck dividendmrk stock reviewmrk stock pricemerck stock pricemerck stock forecastmerck stock predictionmerck stock everything money